2-Chloro-2'-deoxyadenosine (2-CdA) treatment in a patient with Waldenström's macroglobulinaemia complicated by severe neutrocytopenia.
A 68-year-old male patient with newly diagnosed Waldenström's macroglobulinaemia complicated by severe neutrocytopenia at presentation of the disease was treated with 2-CdA. Partial remission with an increase in neutrocyte count was achieved.
Zaucha
J M
JM
Department of Hematology, Medical Academy, Gdańsk, Poland.
Ciesielski
D
D
Grieb
P
P
Hellmann
A
A
D000368:Aged; D000818:Animals; D017338:Cladribine / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D051379:Mice; D009503:Neutropenia / Q000188:drug therapy* / Q000209:etiology; D008258:Waldenstrom Macroglobulinemia / Q000150:complications / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D017338:Cladribine